GeneDx

The standard of care is shifting. Are your testing strategies keeping up? The American Academy of Pediatrics (AAP) recently updated their recommendations: exome and genome sequencing are now recommended as first-tier tests for children with suspected genetic conditions. Technology has advanced. Guidance have caught up. Is your practice aligned with the latest standards? This visual says it all👇 🔗 Learn more: https://genedx.co/4h8pVBH

Access shouldn’t be an afterthought in innovation. GeneDx CEO Katherine Stueland is heading to HLTH USA next week to join industry leaders in a crucial conversation: how do we close the growing gap between groundbreaking therapies and the ability for real people to benefit from them? This panel will dig into the complexity, cost, and opportunity to create a future where life-changing breakthroughs are truly life-changing for every family, especially those navigating rare and genetic conditions. 🗓️ October 22, 2025 in Las Vegas, NV Learn more about Katherine’s panel → https://lnkd.in/e82Di2Uu

As Chief Growth Officer at GeneDx, Melanie Duquette is leading with purpose, expanding access to genetic insights and forging the partnerships that are transforming care for both providers and patients. Her leadership has just been recognized by Women We Admire, naming her one of the Top 50 Women Chief Growth Officers for 2025. Congratulations, Melanie! Thank you for your relentless drive to make a difference.👏 See the full list → https://genedx.co/4nZBdLi

In neonatal critical care, timing is everything. Rapid genome sequencing is reshaping how we respond when every second counts. On Oct 29 at 3 PM ET, join neonatologist Dr. Pankaj Agrawal for a live webinar on how rapid genome sequencing (rGS) is driving faster diagnoses, clearer decision-making, and real change in the NICU. Dr. Agrawal serves as Physician-in-Chief and Chief of Neonatology at Holtz Children’s Hospital/UHealth Jackson Children’s Care. He's also a Professor of Pediatrics and Genetics and Project NewBorn Chair for the University of Miami School of Medicine. In this live webinar, he'll walk through real-world examples and practical approaches to implementation backed by decades of research and experience. 📅 Reserve your seat: https://genedx.co/4h6hRBq

“The tools are here. The evidence is clear. And with collaboration across stakeholders, genomic newborn screening can become the standard of care for every newborn in America.” — Britt Johnson, PhD, FACMG, Head of Medical Affairs at GeneDx   In her recent piece for Fast Company, Britt shares how genomic newborn screening is transforming the diagnostic journey: offering life-changing answers at birth instead of years later.   The GUARDIAN study, the largest of its kind in the U.S., has now screened over 15,000 babies. Among the first 4,000, more than 3% received actionable diagnoses, unlocking earlier treatment and better outcomes.   This is the future of newborn screening, and the future we’re fighting for. One with more answers and less uncertainty. Fewer mysteries and more action.   Let’s make sure it reaches every child.   Read Britt’s article: https://lnkd.in/gyYeG_pu   #Genetics #GeneDxNews #NewbornScreening

Genomic newborn screening (gNBS) is transforming how we identify and treat conditions earlier in life. At the International Consortium on Newborn Sequencing (ICoNS), we’re reaffirming our commitment to advancing gNBS as a critical part of early detection and care. Together with Fabric Genomics, we’re helping bring genomic insights to the forefront so that every baby has access to information that can guide (or even save) their future. If you’re attending ICONS, we’d love to connect. Our team is eager to exchange ideas and collaborate with others working to move this mission forward. #ICONS2025

Every decision in healthcare starts with one thing: remembering the people at the heart of it. On CNBC’s Changemakers and Power Players podcast, our CEO Katherine Stueland reflects on how empathy and courage can shape both teams and, ultimately, the care families receive. “The patients who we are constantly reminded of, they are in these deep moments of vulnerability, and we use that to make courageous decisions.” A thoughtful reminder that compassionate leadership can influence far more than the workplace. You can listen to the full episode here → https://lnkd.in/gdnrNVCX

Welcome Dr. Mimi C. Lee MDPhD, our new Chief Precision Medicine Officer.   As a renowned physician–scientist, neurosurgeon, and healthcare innovator, Dr. Lee has spent her career pushing the boundaries of what’s possible in medicine. She joins us from Advanced Research Projects Agency for Health (ARPA-H) where she helped shape groundbreaking programs like THRIVE, focused on accelerating precision genetic medicines for rare diseases.   Dr. Lee will lead our vision for a new era of lifelong, proactive health powered by genomics - where early answers guide care from day one, and precision medicine becomes the standard.   Her deep expertise across industry, policy, and clinical care will help us build the ecosystem to make that future real, while forging partnerships that enable innovation and help every person live their healthiest life.   Warmest welcomes, Dr. Lee. Let’s build what’s next. 👏 Read more → https://lnkd.in/gPCHSaKT

After testing nearly a million exomes and genomes, we’ve learned one thing: answers matter most when they come early.   Through the Sunshine Genetics Network, Florida is taking the first step toward offering genomic newborn screening (gNBS) to every newborn, creating the first state-backed program of its kind in the United States. GeneDx is proud to be a partner for this groundbreaking program, providing sequencing and analysis services to help families get critical answers before symptoms ever appear.   The future of precision care starts at birth. And it just got a whole lot brighter.   Read more → https://genedx.co/4q9s2cA   #Genomics #PublicHealth #GeneDx #NewbornScreening #gNBS #RareDisease

A new era of preventative care is beginning in Florida. I’m proud to share that GeneDx will serve as the testing and sequencing partner for the Sunshine Genetics Network – the nation’s first state-backed genomic newborn screening (gNBS) program. For the first time, gNBS is moving beyond research and into clinical practice. Through this groundbreaking initiative, Florida will offer gNBS statewide, empowering families and clinicians to diagnose and treat rare diseases before symptoms ever appear. This milestone underscores how genomics can transform public health when applied at scale. With decades of experience and nearly one million exomes and genomes sequenced, GeneDx is honored to support the Sunshine Genetics program in making gNBS part of standard newborn screening for every newborn. Congratulations to Representative Adam Anderson and the Florida Institute for Pediatric Rare Diseases @FSU for their vision and leadership in making this historic advancement possible. The future of medicine – and true longevity – starts at birth. Today, that future feels a bit closer. https://lnkd.in/eVTgU_mS #Genomics #PrecisionMedicine #RareDisease #PublicHealth #Innovation #GeneDx